Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Daheron, Laurence  [Clear All Filters]
2023
Bae J, Kitayama S, Herbert Z, Daheron L, Kurata K, Keskin D, Livak K, Li S, Tarannum M, Romee R, et al. Differentiation of BCMA-specific induced pluripotent stem cells into CD8ab+ T cells targeting myeloma. Blood. 2023.
Zhang H, Daheron L, Cerna-Chavez R, Place EM, Huckfeldt RM, Pierce EA, Garita-Hernandez M. Generation of a human induced pluripotent stem cell line (OGIi001) from peripheral blood mononuclear cells of a healthy male donor. Stem Cell Res. 2023;74:103280.
2021
Daheron L, Diecke S, Healy L, D'Souza S. Cores laboratories: Organization for stem cell technology advancement. Stem Cell Res. 2021;53:102266.
2015
Tsankov AM, Akopian V, Pop R, Chetty S, Gifford CA, Daheron L, Tsankova NM, Meissner A. A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells. Nat Biotechnol. 2015.
Hendriks WT, Jiang X, Daheron L, Cowan CA. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection. Curr Protoc Stem Cell Biol. 2015;34:5B.3.1-5B.3.25.
2014
Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, DeVine A, Ettenger A, Fitzgerald K, Godfrey M, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2014.
2013
Freedman BS, Lam AQ, Sundsbak JL, Iatrino R, Su X, Koon SJ, Wu M, Daheron L, Harris PC, Zhou J, et al. Reduced Ciliary Polycystin-2 in Induced Pluripotent Stem Cells from Polycystic Kidney Disease Patients with PKD1 Mutations. J Am Soc Nephrol. 2013.